PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved a variation application from Pfizer (Malaysia) Sdn Bhd in relation to updating the shelf life of Covid-19 Comirnaty Concentrate for Dispersion for Injection vaccine. Read full story



